ID 202460069 · FY 2018–2024 · 7 years
Georgian Pharmaceuticals (ჯორჯიან ფარმაცევტიკალსი, pharmaceuticals.ge) — despite the name, a medical-device supplier/distributor operating since 2001 (medical devices, consumables and service support), not a manufacturer. Healthy margins; active and growing (revenue ~GEL 3.6m to ~GEL 7.9m).
curated 2026-06-25
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | CAGR |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 5,783 | 4,303 | 3,640 | 5,110 | 6,966 | 6,617 | 7,865 | +5.3% |
| Total COGS | -4,640 | -3,057 | -2,232 | -3,279 | -4,538 | -4,128 | -4,644 | +0.0% |
| Gross Profit | 1,143 | 1,246 | 1,407 | 1,832 | 2,429 | 2,489 | 3,221 | +18.9% |
| Gross Margin | 19.8% | 29.0% | 38.7% | 35.8% | 34.9% | 37.6% | 41.0% | |
| Total Operating Expenses | -139 | -145 | -113 | -492 | -727 | -543 | -441 | +21.3% |
| EBITDA | 1,004 | 1,101 | 1,295 | 1,340 | 1,702 | 1,946 | 2,780 | +18.5% |
| EBITDA Margin | 17.4% | 25.6% | 35.6% | 26.2% | 24.4% | 29.4% | 35.4% | |
| Total D&A | -22 | -8 | -9 | -23 | -22 | -22 | -24 | +1.4% |
| EBIT / Operating Income | 982 | 1,094 | 1,286 | 1,317 | 1,680 | 1,924 | 2,756 | +18.8% |
| Total Interest Income | 17 | 5 | 9 | 9 | 17 | 21 | 51 | +20.3% |
| Total Other Income | 216 | -371 | -142 | 191 | 372 | -514 | -135 | nmf |
| Profit Before Tax | 1,214 | 728 | 1,153 | 1,517 | 2,069 | 1,430 | 2,672 | +14.0% |
| Total Income Tax | -14 | 0 | -207 | -270 | -160 | -54 | 0 | +32.1% |
| Net Profit / (Loss) | 1,205 | 730 | 944 | 1,259 | 1,912 | 1,373 | 2,642 | +14.0% |
| Net Margin | 20.8% | 17.0% | 25.9% | 24.6% | 27.5% | 20.8% | 33.6% |
Ownership & directors from companyinfo.ge (public corporate registry).